India to China: Oseltamivir Export Trade Route

The India to China Oseltamivir corridor is one of India's established pharmaceutical export routes, with 159 shipments documented worth a combined $13.1M USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's oseltamivir manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $82.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with oseltamivir's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 19.4%, placing it at rank #9 among India's top oseltamivir export destinations globally.

On the import side, key buyers of Indian oseltamivir in China include NANJING JULY PHARMACEUTICAL TECHNOL, TO THE ORDER OF, CHONGQING PHARMACEUTICAL (GROUP) CO and 23 others. NANJING JULY PHARMACEUTICAL TECHNOL is the single largest importer with 27 shipments valued at $2.0M USD.

India's oseltamivir exports to China are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 71 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in China benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, NATCO PHARMA LIMITED , NATCO PHARMA LIMITED — together account for 71% of total trade value on this route. The average shipment value of $82.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as oseltamivir phosphate capsules 75 mg (1x10's) and oseltamivir phosphate capsules 75 mg 10s , suggesting that buyers in China tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NANJING JULY PHARMACEUTICAL TECHNOL is the largest importer with 27 shipments worth $2.0M USD — representing 15% of all oseltamivir imports from India on this route. A total of 26 buyers are active on this corridor.